Literature DB >> 13570730

Second field evaluation of bivalent Types 4 and 7 adenovirus vaccine.

M R HILLEMAN, J H GREENBERG, M S WARFIELD, S A ANDERSON, R R GLABERE.   

Abstract

Keywords:  ADENOVIRUS INFECTIONS/prevention and control

Mesh：

Substances：

Year:  1958        PMID： 13570730     DOI： 10.1001/archinte.1958.00030010428013

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  3 in total

1.  II. EFFICACY OF ADJUVANT AND AQUEOUS ADENOVIRUS VACCINES IN PREVENTION OF NAVAL RECRUIT RESPIRATORY DISEASE.

Authors:  L F MILLER; R O PECKINPAUGH; T R ARLANDER; W E PIERCE; E A EDWARDS; P DEBERRY; I A PHILLIPS; M J ROSENBAUM
Journal:  Am J Public Health Nations Health       Date:  1965-01

2.  Vaccination of man with attenuated live adenovirus.

Authors:  G HITCHCOCK; D A TYRRELL; M L BYNOE
Journal:  J Hyg (Lond)       Date:  1960-09

3.  Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon.

Authors:  Ezazul Haque; Urmila Banik; Tahmina Monowar; Leela Anthony; Arun Kumar Adhikary
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.